Xcout Intel
Q'Apel Medical, Inc.
Q'Apel Medical, Inc. is a U.S. medical-device company developing catheter technologies for minimally invasive neurovascular procedures. Its products are intended for clinicians treating conditions such as ischemic stroke and other diseases of the brain’s blood vessels.
Subscribe to see Q'Apel Medical, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Q'Apel Medical, Inc. at a glance
Q'Apel Medical, Inc. is a medical devices company headquartered in United States. It has raised at least $69M across the 3 funding rounds on record. Its most recent funding round raised $17.1M in April 2024. Xcout tracks 10 named people at Q'Apel Medical, Inc., including Stewart Strong (Chief Executive Officer).
Q'Apel Medical, Inc. leadership
- Stewart StrongChief Executive Officer
- Ken PeartreeChief Operating Officer
- John DahldorfChief Financial Officer
- Jeff KrolikChief Technology Officer
- Gene OrloffVice President, Program Management
- Carlos EstradaVice President, Global Marketing
4 more named people on record for Q'Apel Medical, Inc., with roles, board committees and tenure — see the full roster →
Q'Apel Medical, Inc. funding rounds
At least $69M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $17.1M | — | |
| SEC Form D filing | $29.9M | — | |
| — | $22M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Q'Apel Medical, Inc. competitors
A few of Q'Apel Medical, Inc.'s closest competitors — see the full list of competitors and alternatives →
Cognition Med, LLC develops interventional neurovascular medical devices designed to treat stroke patients through minimally-invasive endovascular procedures. The company focuses on creating technologies to remove blood clots from blood vessels in the brain.
Rapid Medical is a medical device company headquartered in Yokneam, Israel, specializing in neurovascular therapy solutions. The company develops advanced medical technologies, such as the DRIVEWIRE 35, and provides innovative treatments for stroke cases globally.
Route 92 Medical is a privately held medical technology company based in San Mateo, California. The company is dedicated to improving patient outcomes through revolutionary procedural changes and advanced neurovascular intervention tools.
Cerenovus, a part of Johnson & Johnson MedTech, is a global leader in neurovascular care. The company is dedicated to changing the trajectory of stroke.
Flow Forward Medical develops an all-in-one, steerable catheter system designed for interventional pulmonary embolism treatment, combining angiography, infusion, and real-time monitoring capabilities. The company serves medical providers by streamlining procedures, optimizing lytic delivery, and tracking clot resolution to improve patient outcomes.
Get Q'Apel Medical, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Q'Apel Medical, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access